American Society of Hematology

Figure 2.

Figure 2. Survival benefit of IMRT over 3D-CRT in early-stage NKTCL. OS and PFS after IMRT or 3D-CRT for the entire cohort (A-B) and for the PSM cohort (C-D).

Survival benefit of IMRT over 3D-CRT in early-stage NKTCL. OS and PFS after IMRT or 3D-CRT for the entire cohort (A-B) and for the PSM cohort (C-D).

This Feature Is Available To Subscribers Only

Sign In or Create an Account